36 Financial Review Genus delivered a strong performance in the year ended 30 June 2015, with adjusted profit before tax up 19% up 23% in constant currency, cash conversion of over 100% and an improved return on adjusted capital invested of 21.2% 2014: 19.2%.
Adjusted earnings per share were up 22% 26% in constant currency.
The effect of the stronger pound Constant on the translation of our overseas Actual currency currency profits reduced the Groups adjusted 2015 2014 Movement Movement Adjusted results m m % % profit before tax for the year by 1.7m or 4% compared with FY14.
Year ended 30 June Unless stated otherwise, this financial Revenue 398.5 372.2 7 8 review quotes constant currency Operating profit 47.2 42.9 10 12 growth rates, which better reflect the Operating profit inc JVs 51.2 44.8 14 18 Groups underlying performance.
Profit before tax 46.6 39.3 19 23 Basic earnings per share p 56.8 46.5 22 26 On a statutory basis, profit before tax was 51% higher and earnings per share were 40% higher in actual 2015 2014 Movement Statutory results m m % currency, primarily due to an increase in the value of our biological assets.
Year ended 30 June However, we continue to use adjusted Revenue 398.5 372.2 7 results as our primary measures of Operating profit 59.5 41.8 42 financial performance as they better Profit before tax 57.8 38.2 51 reflect our underlying progress.
Basic earnings per share p 66.7 47.7 40 Dividend per share p 19.5 17.7 10 Adjusted results are before the movement in the net IAS 41 valuation of biological assets, amortisation of acquired intangible assets, share-based payment expense and exceptional items.
Adjusted results are the measures used by the Board to monitor underlying performance.
Constant currency percentage movements are calculated by restating FY15 results at the exchange rates applied in FY14.
Average Closing Exchange rates 2015 2014 2015 2014 US Dollar 1.57 1.64 1.57 1.71 Euro 1.32 1.20 1.41 1.25 Brazilian Real 4.26 3.75 4.89 3.77 Mexican Peso 22.68 21.44 24.68 22.18 Genus plcAnnual Report 2015 STRATEGIC CORPORATE FINANCIAL ADDITIONAL 37 REPORT GOVERNANCE STATEMENTS INFORMATION Adjusted operating profit Constant Actual currency currency including JVs was 51.2m 2015 2014 Movement Movement Adjusted profit before tax m m % % 2014: 44.8m, up 18% in Genus PIC 57.2 49.9 15 13 constant currency and 14% Genus ABS 24.0 24.3 1 2 in actual currency.
Genus Asia 5.7 6.8 16 9 R&D 28.6 27.7 3 1 Stephen Wilson Central 11.1 10.4 7 5 Group Finance Director Adjusted operating profit 47.2 42.9 10 12 Attributable to non-controlling interest 0.6 Share of JV profits 4.6 1.9 142 174 Adjusted operating profit inc JV 51.2 44.8 14 18 Net finance costs 4.6 5.5 16 18 Adjusted profit before tax 46.6 39.3 19 23 Excludes net IAS 41 valuation movement in biological assets and taxation.
Revenue Genus ABS grew volumes and Performance by Species Revenue grew 8% 7% in actual revenues in all regions but operating The table overleaf shows our global currency to 398.5m 2014: 372.2m, profit was unchanged, with product performance by species, after with Genus PIC growing at 15% helped costs across ABS impacted by the allocating product development by a full year of Gntiporc and a increased mix of sorted semen, costs specific to each species.
higher royalty payments on Genus ABS grew at 9%, while Asia certain leased genomic bulls and Dairy and beef revenues grew 9% declined 9% due to adverse market the depreciation of the Euro and on volumes up by 6%, with growth conditions in Russia.
The rest of Latin American currencies relative strongest in Brazil and our European Asia, without Russia, grew 4%.
to the US Dollar, where most Distribution business and an improved production costs are incurred.
mix towards the higher priced sorted Adjusted Operating Profit Including semen, particularly in North America Joint Ventures Profits in Genus Asia, including JVs, and Asia.
Sales of semen from our Adjusted operating profit including were unchanged.
The Asia bovine global studs, which represent 77% JVs was 51.2m 2014: 44.8m, up business achieved high single digit of semen sales by volume, increased 18% in constant currency and 14% in growth, helped by China, where by 8%.
Profits were stable, primarily actual currency.
Genuss share of JV we continued to develop and due to increased ABS product costs.
profits was higher at 4.6m 2014: strengthen our sales channels.
The 1.9m, helped by continuing strong Asia porcine business achieved Porcine revenues grew by 9%, with growth at Agroceres PIC in Brazil strong growth in PIC Philippines and royalty income up 15% to 77.1m.
and an improved performance by costs were reduced in PIC China.
Volumes were up 6% including Besun in China, following the high However, these improvements were Agroceres PIC, our JV in Brazil, mainly start-up costs during the prior year.
more than offset by declines in our due to a strong product portfolio, a Russia porcine business caused full year of the Gntiporc acquisition Genus PIC had a very strong year, by adverse market conditions.
and strong performances across with profits including JVs up 17%.
However, Russia and Volume growth of 8% benefited R&D costs increased by 1%.
Increases China volumes declined by double from a full year of the Gntiporc in key research investments, expansion digits.
Profits were up 22% on 2014, acquisition, another strong year in of our beef and dairy nuclei and due to Latin Americas continued Latin America and growth in royalty additional investments in product robust growth, the early completion volumes in North America, following validation and genomic testing of synergies from Gntiporc and the PEDv outbreak in the prior year.
were largely offset by the benefit of a somewhat improved result in strong by-product slaughter prices China as we reduced costs there.
and early exit from the Gntiporc Quebec porcine nucleus.
Genus plcAnnual Report 2015 38 Financial Review continued Biological Assets Constant Actual currency currency A feature of the Groups net assets is its substantial investment in biological 2015 2014 Movement Movement Performance by species m m % % assets, which IAS 41 requires us to state at fair value.
At 30 June 2015, Revenue the carrying value of biological Dairy and beef 183.4 171.8 7 9 assets was 315.9m 2014: 275.5m, Porcine 201.3 184.9 9 9 as set out in the table opposite.
R&D 13.8 15.5 11 12 398.5 372.2 7 8 The movement in the overall carrying value of biological assets, Adjusted operating profit inc JV excluding the effect of exchange Dairy and beef 14.5 15.7 8 0 rate translation changes, includes: Porcine 52.4 43.1 22 22 a 20.4m increase in the carrying Central and research 15.7 14.0 12 11 value of porcine biological assets, due principally to higher value 51.2 44.8 14 18 animals, particularly boars, in the pure line herds as well as an Finance Costs Taxation increase in the number of animals Net finance costs reduced by The effective rate of tax for the year, sold on royalty contracts: and 0.9m to 4.6m 2014: 5.5m and based on adjusted profit before a 4.5m increase in dairy and beef include IAS 19 pension interest of tax, was 26.0% 2014: 28.2%, with biological assets, arising from an 2.3m 2014: 2.9m.
Higher net the decrease primarily due to the increase in the number of beef bulls borrowings following the acquisitions benefit of a full year of the UK as well as an increased sales of Birchwood and IVB, and higher finance company tax regime and demand for beef units.
capital spending were offset by favourable prior period adjustments.
lower average interest rates, due The historical cost of these assets, less to the renewal of US$60m of fixed The effective rate remains higher depreciation, was 34.1m at 30 June interest rate cover at lower rates.
than the UK corporate tax rate.
2015 2014: 36.2m, which is the This is due to the mix of overseas basis used for the adjusted results.
Exceptional Items profits, particularly the proportion There was a 5.1m net exceptional of profits generated in the US, Retirement Benefit Obligations expense in 2015 2014: 2.0m where the statutory tax rate The Groups retirement benefit expense, of which 1.4m was for is approximately 39%, and the obligations at 30 June 2015, calculated acquisition and integration related impact of withholding taxes on the in accordance with IAS 19, were expenses, primarily Birchwood and repatriation of funds to the UK.
63.1m 2014: 58.2m before tax IVB, 2.8m was for ongoing legal and 49.9m 2014: 46.1m net of fees in Genus ABSs case against The tax rate on statutory profits was related deferred tax.
The largest Sexing Technologies see note 7, 29.9% 2014: 24.3%.
In addition to the element of the liability relates to the and 1.3m was for restructuring factors mentioned above, there was an multi-employer Milk Pension Fund, costs, with a 0.4m settlement gain unfavourable impact in the year due where we continue to account on related to the Milk Pension Fund.
to the majority of the IAS41 biological the basis of Genus being responsible assets valuation movement having for 75% of the plans funding.
Statutory Profit Before Tax deferred tax applied at US rates.
Operating profit on a statutory basis During the year, contributions was 59.5m, 2014: 41.8m while Earnings Per Share payable in respect of the Groups our statutory profit before tax was Adjusted basic earnings per share, defined benefit schemes amounted 57.8m 2014: 38.2m.
The statutory including the benefit of the lower to 6.1m 2014: 5.6m.
results benefit from an increase of tax rate, increased by 22% to 56.8 24.9m 2014: 7.5m in the net IAS 41 pence 2014: 46.5 pence and rose Cash Flow valuation of biological assets driven 26% in constant currency.
Basic Cash generated by operations largely by the strength of the porcine earnings per share on a statutory remained strong at 50.7m business.
Amortisation of acquired basis were 66.7 pence 2014: 47.7 2014: 44.3m.
Conversion of intangible assets and exceptional items pence, an increase of 40%.
adjusted operating profit into cash increased following the Gntiporc, was 107% 2014: 103% before Birchwood and IVB acquisitions.
The capital expenditure, investments, Board believes the volatile nature interest, tax and dividends.
of these items, most of which are non-cash, is less representative of the Groups underlying performance than adjusted measures.
Genus plcAnnual Report 2015 STRATEGIC CORPORATE FINANCIAL ADDITIONAL 39 REPORT GOVERNANCE STATEMENTS INFORMATION The return on invested 2015 2014 Biological assets m m capital increased to 21.2% Non-current assets 242.7 208.9 after tax 2014: 19.2%.
Current assets 50.2 44.1 Inventory 23.0 22.5 315.9 275.5 Represented by: Porcine 148.1 124.4 Dairy and beef 167.8 151.1 315.9 275.5 2015 2014 Cash flow before debt repayments m m Cash generated by operations 50.7 44.3 Interest, tax and dividends 27.0 22.1 Investments 11.1 34.1 Capital expenditure 14.8 6.6 Other 2.6 0.5 0.4 18.0 Adjusted operating profit 47.2 42.9 Cash conversion 107% 103% This performance was generated by The Groups financial position remains Dividend continued strong working capital Reflecting the Boards continuing strong and there is substantial management and the benefit of the headroom of 51.1m under our confidence in the prospects for exit from the Quebec nucleus.
the Group, it is recommending borrowing facilities of 138.1m, which run to September 2017. to shareholders a final dividend The cash outflow from investments of 13.4pence per ordinary share, was 11.1m, primarily from the Our borrowing ratios are strong.
resulting in a total dividend for the acquisitions of Birchwood and IVB.
year of 19.5 pence per ordinary Interest cover was 31.9 times 2014: This compares with 34.1m from 20.6 times.
The ratio of net debt share, an increase of 10% for the year.
the Gntiporc acquisition and Dividend cover remains strong, with to EBITDA, as calculated under our Besun JV investment in 2014.
The financing facilities, remained the the dividend covered 2.9 times by increase in capital expenditure of adjusted earnings 2014: 2.6 times.
same as the prior year at 1.2 times.
8.2m to 14.8m 2014: 6.6m included increased investment in GSS Return on Invested Capital technology.
The total cash inflow We measure our return on invested Stephen Wilson for the year after these investments, Group Finance Director capital on the basis of adjusted interest, tax and dividends was operating profit including JVs after 0.4m 2014: outflow 18.0m.
tax divided by the operating net assets of the business, stated on the Net Debt basis of historical cost, excluding While cash flow was positive, net net debt and pension liability.
debt increased from 63.9m to This removes the impact of IAS 41 71.8m at 30 June 2015, due to the fair value accounting, the related impact of exchange movements, as deferred tax and goodwill.
The our borrowings are denominated return on invested capital increased primarily in US Dollars.
